Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000

Pediatrics
Theoklis E ZaoutisWilliam J Steinbach

Abstract

Invasive aspergillosis (IA) is the most common filamentous fungal infection observed in immunocompromised patients. The incidence of invasive aspergillosis has increased significantly in recent decades in parallel with the increasing number and improved survival of immunocompromised patients. IA in adults has been well characterized; however, only a few small studies of IA in children have been reported. Therefore, the objective of this study was to describe the incidence and outcomes of children with IA. We performed a retrospective cohort study using the 2000 Kids Inpatient Database, a national database of hospital inpatient stays during 2000. IA was defined as aspergillosis that occurred in a child with malignancy (solid tumor, leukemia, or lymphoma), hematologic/immunologic deficiency, or transplant (bone marrow or solid organ). Discharge weighting was applied to the data to obtain nationally representative estimates of disease. During 2000, there were an estimated 666 pediatric cases of IA among 152,231 immunocompromised children, yielding an annual incidence of 437/100,000 (0.4%) among hospitalized immunocompromised children. Children with malignancy accounted for the majority (74%) of cases of IA. The highest incidence o...Continue Reading

Citations

Jun 5, 2012·European Journal of Clinical Pharmacology·Antonio RuggieroRiccardo Riccardi
Aug 1, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T LehrnbecherD Schwabe
Nov 22, 2007·Wiener medizinische Wochenschrift·Philipp StaberPeter Neumeister
May 16, 2009·Medical Mycology·Georg MaschmeyerJohn Perfect
Oct 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L PaganoF Aversa
Nov 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lennert SlobbeBart J A Rijnders
Nov 15, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Athanasios TragiannidisAndreas H Groll
Dec 17, 2008·Antimicrobial Agents and Chemotherapy·Mats O KarlssonPeter A Milligan
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·Thomas J WalshIrja Lutsar
Jan 13, 2010·Clinical Microbiology Reviews·Nicasio ManciniMassimo Clementi
Feb 24, 2012·Annals of Intensive Care·Olivier BrissaudTheoklis Zaoutis
Feb 9, 2012·International Journal of Molecular Sciences·Maria Teresa MontagnaGiorgina Specchia
Jul 16, 2013·Journal of Global Infectious Diseases·Mojtaba NabiliSeyed Reza Aghili
Nov 8, 2013·The Journal of Antimicrobial Chemotherapy·Sara YunusAndreas H Groll
Aug 16, 2008·The Pediatric Infectious Disease Journal·Randall HaydenThomas J Walsh
Nov 8, 2008·The Pediatric Infectious Disease Journal·Priya A PrasadTheoklis E Zaoutis
Jul 28, 2009·The Pediatric Infectious Disease Journal·Hans Jürgen DornbuschAndreas H Groll
Jun 1, 2012·Journal of the Pediatric Infectious Diseases Society·Thomas Lehrnbecher, Andreas H Groll
Oct 23, 2012·Current Fungal Infection Reports·Michail S Lionakis
Jun 7, 2007·European Journal of Pediatrics·Charalampos AntachopoulosEmmanuel Roilides
Mar 23, 2011·Expert Review of Anti-infective Therapy·Georg Maschmeyer
Mar 23, 2011·Expert Review of Anti-infective Therapy·Thomas Lehrnbecher, Andreas H Groll
Nov 19, 2010·Expert Review of Hematology·Hana Hakim, Jerry L Shenep
Dec 2, 2008·Expert Opinion on Pharmacotherapy·Ioanna FiliotiEmmanuel Roilides
Feb 26, 2016·Clinical and Translational Imaging : Reviews in Nuclear Medicine and Molecular Imaging·Alfred O AnkrahAndor W J M Glaudemans
Feb 11, 2011·Expert Opinion on Drug Safety·Oliver A CornelyAndrew J Ullmann
Jun 2, 2010·Current Medical Research and Opinion·William J Steinbach
Aug 18, 2012·The Journal of Infection·William J SteinbachDavid L Horn
Nov 15, 2011·European Journal of Internal Medicine·Parisa BadieeMehrvash Joukar
Apr 9, 2011·Enfermedades infecciosas y microbiología clínica·Jesús FortúnUNKNOWN Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED)
Jun 28, 2011·Revista iberoamericana de micología·Guillermo Quindós
Feb 1, 2011·Early Human Development·Elio CastagnolaRiccardo Haupt
Mar 6, 2010·Enfermedades infecciosas y microbiología clínica·Isabel Ruiz-CampsUNKNOWN Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED)
Nov 3, 2009·Paediatric Respiratory Reviews·Elpis HatziagorouEmmanuel Roilides
Jun 25, 2009·Seminars in Hematology·L Charles BaileySusan R Rheingold
Dec 8, 2006·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·N Le GuyaderG Leverger
May 6, 2009·Pediatric Blood & Cancer·Jessica BateRichard Pebody

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Reginald E GreeneRobert H Rubin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Thomas J WalshInfectious Diseases Society of America
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
B de PauwNational Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
© 2021 Meta ULC. All rights reserved